CHICAGO SAYS PFIZER AGREES TO DISCLOSE RISKS OF OPIOIDS

  • News
  • July 15, 2016
The city of Chicago says it has reached an agreement with Pfizer committing the drugmaker to disclosing the risks of addiction in its marketing of prescription opioid painkillers. Chicago is suing five pharmaceutical companies, alleging they have misrepresented the benefits of opioids while concealing serious health risks associated with the drugs. Pfizer Inc. is not named in the lawsuit. But Mayor Rahm Emanuel’s office said in its announcement that Pfizer has cooperated with the city’s investigation and the legal action. The agreement with Pfizer also bars it from supporting organization or individual who make inaccurate claims about the risks and benefits of opioids.

Related Posts

13 Years after Oxytocin Order, HC Seeks Compilance Status

GWALIOR: The Gwalior Bench of the Madhya Pradesh High Court has directed the state government to submit a comprehensive compliance status report. This order addresses the implementation of the court’s…

Centre Pushes Haryana to Fast-Track AIIMS Rewari

New Delhi | August 18, 2025 — The Union government has urged Haryana to speed up work on AIIMS Rewari (Majra) and resolve on-ground hurdles so the institute can open…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Eluru police arrest five medical shop owners for illegal sale of Tramadol injections

Eluru police arrest five medical shop owners for illegal sale of Tramadol injections

KAISHA Pharma establishes Kaisha Pharma International in Italy

KAISHA Pharma establishes Kaisha Pharma International in Italy

Apollo Navi Mumbai launches geriatric oncology clinic

Apollo Navi Mumbai launches geriatric oncology clinic

Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

Himachal DCA honoured with ‘Regulatory Excellence Award’ at iPHEX 2026

Himachal DCA honoured with ‘Regulatory Excellence Award’ at iPHEX 2026

Baddi pharma firm loses licence after 1,200-kg tapentadol haul

Baddi pharma firm loses licence after 1,200-kg tapentadol haul